EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

One-Pot Synthesis and Biological Evaluation of Piperidinium-3,3'-(arylmethylene) bis-lawsone derivatives by targeting caspase-7

Elvira Hermawati, Muhammad Taufik, Ade Danova, Warinthorn Chavasiri, Didin Mujahidin

Indonesian Journal of Pharmacy · 08.12.2025 · 661-670

DOI: 10.22146/ijp.16734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Pharmacy, online erschienen am 08.12.2025. Verfasst von Elvira Hermawati und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 2.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Caspase-7, an effector enzyme activated by the initiator caspase-1, plays a crucial role in triggering apoptosis. It is also a significant factor in neurodegenerative conditions like Alzheimer's and Huntington's diseases. While both peptide and nonpeptide caspase inhibitors have shown promise in preclinical research, peptide inhibitors face challenges such as poor cell permeability, brief half-life, limited efficacy, and complex structures that are difficult to optimize. Additionally, they encounter bioavailability issues. Consequently, the development of nonpeptide-based caspase inhibitors remains an area of interest for researchers. Using a multicomponent reaction, eight lawsone derivatives, specifically piperidinium-3,3'-(arylmethylene) bis-lawsone, were successfully synthesized. This group included five novel compounds (2, 3, 4, 7, 8) and three previously known ones (1, 5, 6). The products were analyzed using Nuclear Magnetic Resonance (NMR) 1-2D spectroscopy and High Resolution Mass Spectrometry (HRMS), followed by an evaluation of their inhibitory activity against caspase-7. Notably, this study marks the first instance of piperidinium-3,3'-(arylmethylene) bis-lawsone being investigated for its potential to target the caspase-7 enzyme. Among the eight compounds, compound 8 demonstrated the most promising results, exhibiting an inhibitory activity of approximately 29.80% against caspase-7. This finding suggests that compound 8 could serve as a valuable fragment molecule for future development of caspase-7 inhibitors.

Zitieren

APA

Hermawati, E., Taufik, M., Danova, A., Chavasiri, W., & Mujahidin, D. (2025). One-Pot Synthesis and Biological Evaluation of Piperidinium-3,3'-(arylmethylene) bis-lawsone derivatives by targeting caspase-7. Indonesian Journal of Pharmacy, 661-670. https://doi.org/10.22146/ijp.16734

Vancouver

Hermawati E, Taufik M, Danova A, Chavasiri W, Mujahidin D. One-Pot Synthesis and Biological Evaluation of Piperidinium-3,3'-(arylmethylene) bis-lawsone derivatives by targeting caspase-7. Indonesian Journal of Pharmacy. 2025:661-670. doi:10.22146/ijp.16734

BibTeX
@article{Hermawati2025,
  author = {Hermawati, Elvira and Taufik, Muhammad and Danova, Ade and Chavasiri, Warinthorn and Mujahidin, Didin},
  title = {One-Pot Synthesis and Biological Evaluation of Piperidinium-3,3'-(arylmethylene) bis-lawsone derivatives by targeting caspase-7},
  journal = {Indonesian Journal of Pharmacy},
  year = {2025},
  pages = {661--670},
  doi = {10.22146/ijp.16734}
}
Kostenlos starten →